NCT00367939View on ClinicalTrials.gov

Efficacy and Safety of the Combination of Valsartan Plus Amlodipine in Hypertensive Patients Not Adequately Responding to the Combination Therapy With Ramipril Plus Felodipine

PHASE3CompletedINTERVENTIONAL
Enrollment

132

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

July 31, 2006

Study Completion Date

July 31, 2006

Conditions
Hypertension
Interventions
DRUG

valsartan + amlodipine

Trial Locations (1)

Unknown

Investigative Centers

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY

NCT00367939 - Efficacy and Safety of the Combination of Valsartan Plus Amlodipine in Hypertensive Patients Not Adequately Responding to the Combination Therapy With Ramipril Plus Felodipine | Biotech Hunter | Biotech Hunter